Who owns Champions Oncology?
- Ticker: CSBR
- CUSIP Number: 15870p307
Tip: Access positions for across all investors
Analyze quarterly positions in Champions Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Champions Oncology stock
Who bought or sold Champions Oncology this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Battery Management Corp. | 2.4M | $12M | 0% | Mar 2024 |
|
| NEA Management Company | 1.7M | $8.4M | 0% | Mar 2024 |
|
| Tocqueville Asset Management | 685k | $3.4M | 0% | Mar 2024 |
|
| BlackRock | 116k | $567k | -1% | Mar 2024 |
|
| Vanguard Group | 86k | $420k | 3% | Mar 2024 |
|
| Essex Investment Management | 77k | $378k | 0% | Mar 2024 |
|
| Goldman Sachs Group | 69k | $340k | 100% | Mar 2024 |
|
| Geode Capital Management | 62k | $304k | 1% | Mar 2024 |
|
| Northern Trust | 43k | $209k | 38% | Mar 2024 |
|
| Morgan Stanley | 41k | $199k | 267% | Mar 2024 |
|
| HighTower Advisors | 34k | $168k | 10% | Mar 2024 |
|
| Acadian Asset Management | 31k | $148k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 27k | $131k | -13% | Mar 2024 |
|
| Bank of America Corporation | 26k | $127k | 0% | Mar 2024 |
|
| Citadel Advisors | 25k | $121k | -2% | Mar 2024 |
|
| Mesirow Financial Investment Management International Equity | 12k | $61k | 100% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 12k | $60k | 100% | Mar 2024 |
|
| Stifel Financial | 11k | $55k | 100% | Mar 2024 |
|
| Simplex Trading | 1.6k | $7.0k | 100% | Mar 2024 |
|
| UBS Group | 1.1k | $5.4k | -50% | Mar 2024 |
|
| Royal Bank of Canada | 64.00 | $0 | -71% | Mar 2024 |
|
| Wells Fargo & Company | 47.00 | $229.999200 | 2% | Mar 2024 |
|
| Jpmorgan Chase & Co | 11.00 | $54.000100 | -89% | Mar 2024 |
|
Who sold out of Champions Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ameriprise Financial | Sep 2023 | 84k | $523k |
| Dimensional Fund Advisors | Dec 2023 | 27k | $145k |
| Aristides Capital | Sep 2023 | 22k | $134k |
| Susquehanna International | Sep 2023 | 13k | $83k |
| Tower Research Capital | Sep 2023 | 21.00 | $130.000500 |